Maxwell O Akanbi1, Babafemi O Taiwo2, Chad J Achenbach2, Obianuju B Ozoh3, Daniel O Obaseki4, Halima Sule5, Oche O Agbaji1, Christiana O Ukoli1. 1. Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria. 2. Northwestern University Chicago, USA. 3. Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria. 4. Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria. 5. Department of Family Medicine, Jos University Teaching Hospital, Nigeria.
Abstract
OBJECTIVE: To determine the prevalence and risk factors for chronic obstructive pulmonary disease (COPD) among HIV-infected adults in Nigeria. DESIGN: Cross-sectional study. METHODS: HIV-infected adults aged ≥ 30 years with no acute ailments accessing care at the antiretroviral therapy clinic of Jos University Teaching Hospital were enrolled consecutively. Participants were interviewed to obtain pertinent demographic and clinical information, including exposure to risk factors for COPD. Post-bronchodilator spirometry was carried out. HIV related information was retrieved from the clinic medical records. COPD case-definition was based on the Global Initiative for Obstructive Lung Disease (GOLD) criteria using post-bronchodilator FEV1/FVC <0.7. COPD prevalence was also calculated using the lower limit of normal for FEV1/FVC criteria (LLN) from the European Respiratory Society normative equation. Factors associated with COPD were determined using logistic regression models. RESULTS: Study population comprised 356 HIV infected adults with mean age of 44.5 (standard deviation, 7.1) years and 59% were female. The mean time elapsed since HIV diagnosis was 7.0 (SD, 2.6) years and 97.5% of the respondents were on stable ART with virologic suppression present in 67.2%. Prevalence of COPD were 15.4% (95% confidence interval [CI] 11.7-19.2), 12.07% (95% CI 8.67-15.48), 22.19% (95% CI 18.16-26.83) using GOLD, ERS LLN and GLI LLN diagnostic criteria respectively. In multivariate analyses adjusting for gender, exposure to cigarette smoke or biomass, history of pulmonary tuberculosis, use of antiretroviral therapy, current CD4 T-cell count and HIV RNA, only age > 50 years was independently associated with COPD with OR 3.4; 95% CI 1.42-8.17 when compared to ages 30-40 years. CONCLUSION: HIV-associated COPD is common in our population of HIV patients.
OBJECTIVE: To determine the prevalence and risk factors for chronic obstructive pulmonary disease (COPD) among HIV-infected adults in Nigeria. DESIGN: Cross-sectional study. METHODS:HIV-infected adults aged ≥ 30 years with no acute ailments accessing care at the antiretroviral therapy clinic of Jos University Teaching Hospital were enrolled consecutively. Participants were interviewed to obtain pertinent demographic and clinical information, including exposure to risk factors for COPD. Post-bronchodilator spirometry was carried out. HIV related information was retrieved from the clinic medical records. COPD case-definition was based on the Global Initiative for Obstructive Lung Disease (GOLD) criteria using post-bronchodilator FEV1/FVC <0.7. COPD prevalence was also calculated using the lower limit of normal for FEV1/FVC criteria (LLN) from the European Respiratory Society normative equation. Factors associated with COPD were determined using logistic regression models. RESULTS: Study population comprised 356 HIV infected adults with mean age of 44.5 (standard deviation, 7.1) years and 59% were female. The mean time elapsed since HIV diagnosis was 7.0 (SD, 2.6) years and 97.5% of the respondents were on stable ART with virologic suppression present in 67.2%. Prevalence of COPD were 15.4% (95% confidence interval [CI] 11.7-19.2), 12.07% (95% CI 8.67-15.48), 22.19% (95% CI 18.16-26.83) using GOLD, ERS LLN and GLI LLN diagnostic criteria respectively. In multivariate analyses adjusting for gender, exposure to cigarette smoke or biomass, history of pulmonary tuberculosis, use of antiretroviral therapy, current CD4 T-cell count and HIV RNA, only age > 50 years was independently associated with COPD with OR 3.4; 95% CI 1.42-8.17 when compared to ages 30-40 years. CONCLUSION:HIV-associated COPD is common in our population of HIVpatients.
Authors: A Bénard; J F Tessier; J Rambeloarisoa; F Bonnet; H Fossoux; D Neau; H Dutronc; E Lazaro; F Dabis; G Chêne Journal: Int J Tuberc Lung Dis Date: 2006-04 Impact factor: 2.373
Authors: Maxwell O Akanbi; Chad J Achenbach; Joe Feinglass; Babafemi Taiwo; Adamu Onu; Mai T Pho; Oche Agbaji; Phyllis Kanki; Robert L Murphy Journal: AIDS Res Hum Retroviruses Date: 2013-02-25 Impact factor: 2.205
Authors: Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange Journal: PLoS One Date: 2013-12-18 Impact factor: 3.240
Authors: Engi F Attia; Elizabeth Maleche-Obimbo; T Eoin West; Lilian Ndukwe-Wambutsi; Catherine Kiptinness; Anthony Cagle; Christine J McGrath; Celestine K Mugambi; Neveen G El Antouny; Sherry Eskander; Michael H Chung; Kristina Crothers Journal: AIDS Date: 2018-06-19 Impact factor: 4.177
Authors: Sithembile L Mabila; Kirsten S Almberg; Lee Friedman; Robert A Cohen; Ntombizodwa Ndlovu; Naseema Vorajee; Jill Murray Journal: Int Arch Occup Environ Health Date: 2019-11-07 Impact factor: 3.015
Authors: Crystal M North; Joseph G Allen; Samson Okello; Ruth Sentongo; Bernard Kakuhikire; Edward T Ryan; Alexander C Tsai; David C Christiani; Mark J Siedner Journal: Lung Date: 2017-12-19 Impact factor: 2.584
Authors: Alex Kayongo; Adaeze C Wosu; Tasmia Naz; Faith Nassali; Robert Kalyesubula; Bruce Kirenga; Robert A Wise; Trishul Siddharthan; William Checkley Journal: COPD Date: 2020-05-28 Impact factor: 2.409
Authors: Yvetot Joseph; Zhiwen Yao; Akanksha Dua; Patrice Severe; Sean E Collins; Heejung Bang; Marc Antoine Jean-Juste; Oksana Ocheretina; Alexandra Apollon; Margaret L McNairy; Kathryn Dupnik; Etienne Cremieux; Anthony Byrne; Jean W Pape; Serena P Koenig Journal: J Int AIDS Soc Date: 2021-07 Impact factor: 5.396
Authors: Ken M Kunisaki; Mehdi Nouraie; Robert L Jensen; Dong Chang; Gypsyamber D'Souza; Meghan E Fitzpatrick; Meredith C McCormack; Valentina Stosor; Alison Morris Journal: AIDS Date: 2020-07-01 Impact factor: 4.632